Encouraging patient compliance

Review the signs and symptoms of an HAE attack with your patients

Review the signs and symptoms of an attack with your patients

  • Hereditary angioedema (HAE) attacks typically cause swelling of the skin/subcutaneous tissues, the gastrointestinal tract/abdomen, and the upper airways, including the larynx.1-3
  • Many patients may experience prodromal signs before an HAE attack, including a tingling sensation, erythema marginatum (a mild, nonpruritic rash), fatigue, and nausea1,4
Reinforce the importance of early treatment

Reinforce the importance of early treatment

  • The US Hereditary Angioedema Association Medical Advisory Board guidelines state that on-demand treatment of attacks is most effective when administered early in the attack.5
    • All patients with HAE due to C1INH deficiency should have access to at least 2 standard doses of on-demand treatment.5
    • All attacks, regardless of location, should be considered for treatment as soon as patients recognize the symptoms5
  • The Hereditary Angioedema International Working Group guidelines recommend that on-demand treatment for acute attacks should be the initial goal of therapy for all patients3
  • The World Allergy Organization guidelines recommend that all patients with HAE should carry their on-demand treatment at all times6
Recommend FIRAZYR for all acute HAE attacks-whether they occur at home or away

Recommend FIRAZYR for all acute HAE attacks—whether they occur at home or away

  • As the only prefilled, self-administered, subcutaneous injection, FIRAZYR is ready to use as soon as an attack strikes—no mixing, special handling or refrigeration needed7
  • FIRAZYR demonstrated faster symptom relief when compared to placebo in clinical trials7
  • Nine out of 10 HAE attacks were treated with only one injection of FIRAZYR in clinical trials (n=582) and in an international observational study (n=1657)7,8
  • FIRAZYR is the only B2 receptor antagonist designed to block receptor activation, thereby treating the localized swelling and pain associated with acute HAE attacks7,9
Reevaluate each patient's on-demand treatment plan regularly

Reevaluate each patient’s on-demand treatment plan regularly

  • Make sure your patients are prepared with a detailed treatment plan5,6
  • Monitor frequency of attacks and efficacy of treatment5